---
title: "PROK.US (PROK.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PROK.US/news.md"
symbol: "PROK.US"
name: "PROK.US"
parent: "https://longbridge.com/en/quote/PROK.US.md"
datetime: "2026-03-13T07:55:20.637Z"
locales:
  - [en](https://longbridge.com/en/quote/PROK.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PROK.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PROK.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/PROK.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/PROK.US/news.md)


# PROK.US (PROK.US) — Related News

### [ProKidney (PROK) Projected to Post Earnings on Monday](https://longbridge.com/en/news/278335975.md)
*2026-03-09T06:05:08.000Z*
> ProKidney (NASDAQ:PROK) is set to release its Q4 2025 earnings on March 16, with analysts predicting a loss of $0.16 per

### [ProKidney Corp. (NASDAQ:PROK) Given Average Rating of "Hold" by Analysts](https://longbridge.com/en/news/276841845.md)
*2026-02-25T06:23:18.000Z*
> ProKidney Corp. (NASDAQ:PROK) has received an average analyst rating of "Hold" from seven analysts. Among them, two anal

### [HC Wainwright Forecasts ProKidney FY2030 Earnings](https://longbridge.com/en/news/274812017.md)
*2026-02-04T12:26:31.000Z*
> HC Wainwright has forecasted ProKidney Corp. (NASDAQ:PROK) to achieve earnings per share of $0.20 for FY2030, maintainin

### [Prokidney Corp - Topline Data Readout Of Surrogate Endpoint Expected Q2 2027](https://longbridge.com/en/news/274559451.md)
*2026-02-02T21:23:08.000Z*
### [ProKidney (NASDAQ:PROK) Stock Price Down 5.5%  - What's Next?](https://longbridge.com/en/news/272736646.md)
*2026-01-15T18:42:58.000Z*
> ProKidney Corp. (NASDAQ:PROK) shares fell 5.5% to $2.1550, with trading volume down 63% from average levels. Analysts ha

### [ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference | PROK Stock News](https://longbridge.com/en/news/271653016.md)
*2026-01-06T04:30:00.000Z*
> ProKidney Corp. (Nasdaq: PROK) will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, at

### [ProKidney (NASDAQ:PROK) Director Sells $1,190,062.32 in Stock](https://longbridge.com/en/news/266037691.md)
*2025-11-15T15:17:04.000Z*
> ProKidney Corp. Director Brian Jg Pereira sold 502,136 shares of the company's stock for $1,190,062.32 on November 13th.

### [Director’s Major Stock Sale Shakes Up ProKidney!](https://longbridge.com/en/news/266006285.md)
*2025-11-15T02:09:59.000Z*
> Director Brian Jg Pereira sold 757,162 shares of ProKidney, totaling $1,883,733, impacting the company's stock. ProKidne